Long-term treatment with lanthanum carbonate reduces mineral and bone abnormalities in rats with chronic renal failure

Background. Lanthanum carbonate (FOSRENOL(®), Shire Pharmaceuticals) is an effective non-calcium, non-resin phosphate binder for the treatment of hyperphosphataemia in patients with chronic kidney disease (CKD). In this study, we used a rat model of chronic renal failure (CRF) to examine the long-te...

Descripción completa

Detalles Bibliográficos
Autores principales: Damment, Stephen, Secker, Roger, Shen, Victor, Lorenzo, Victor, Rodriguez, Mariano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107768/
https://www.ncbi.nlm.nih.gov/pubmed/21098011
http://dx.doi.org/10.1093/ndt/gfq682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107768/
https://www.ncbi.nlm.nih.gov/pubmed/21098011
http://dx.doi.org/10.1093/ndt/gfq682

Ejemplares similares